Please login to the form below

Not currently logged in
Email:
Password:

S-A and Boehringer team up for AF campaign

Sanofi-aventis and Boehringer Ingelheim are to work with the World Heart Federation to raise awareness of atrial fibrillation
The World Heart Federation, sanofi-aventis (S-A) and Boehringer Ingelheim are to collaborate on the AF AWARE (Atrial Fibrillation Awareness And Risk Education) campaign to raise awareness of atrial fibrillation (AF) and its links to severe consequences including cardiovascular (CV) mortality, stroke and CV hospitalisations. 

The campaign aims to promote education around the risks associated with AF, as well as highlight the importance of early diagnosis and comprehensive management to maximise patient outcomes.

Johanna Ralston, CEO of the World Heart Federation, said: "The AF AWARE campaign was established to specifically address the lack of awareness and endeavours to draw attention to this serious, chronic, disease, the consequences of which can have devastating effects on patients and healthcare systems."

The World Heart Federation will lead the initiative internationally and will also work closely with the Stroke Alliance for Europe and the Atrial Fibrillation Association to deliver the programme. 

Agreements have been established with sanofi-aventis and Boehringer Ingelheim for a co-sponsorship, with both companies providing funding for the campaign.

15th February 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics